Viking Therapeutics shares jump on maintenance study top-line results
Viking Therapeutics said it has positive top-line results from a maintenance study of its weight-loss drug; the stock rose 39% to $41.85 in premarket on Tuesday.
Story updates
11:34:49 AM UTC
SquawkNews
By Mariapaula GonzalezPower electronics company Vicor jumped Tuesday after nearly doubling its sequential revenue growth guidance, driven by royalty fees from a new patent license deal for its artificial-intelligence-power technology.Vicor raised its sequential revenue growth forecast for the fisca…